ClinConnect ClinConnect Logo
Search / Trial NCT05789953

PrEventing PostoPERative Pulmonary Complications by Establishing a MachINe-learning assisTed Approach

Launched by BRITTA TRAUTWEIN · Mar 16, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Machine Learning Lung Ultrasound

ClinConnect Summary

This clinical trial is studying a new way to prevent serious breathing problems that can occur after surgery, especially for patients who have undergone general anesthesia. The researchers want to find out if a special computer program, called a machine learning algorithm, can help identify patients at higher risk for these complications by analyzing their medical data and ultrasound images taken in the recovery room. The trial will include 512 adult patients who are having planned surgeries and are expected to stay in the hospital afterward.

To participate in this study, patients need to be at least 18 years old and scheduled for an elective surgery that requires general anesthesia. Those who are having outpatient surgery or who might need to go to the intensive care unit afterward will not be included. If you join the study, you will be monitored for any breathing issues after your surgery, and the aim is to catch any problems early, before they become serious. This research could ultimately help improve safety and outcomes for patients undergoing surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adult patients
  • elective, surgical procedure
  • general anaesthesia
  • Exclusion Criteria:
  • patients younger than 18 years of age
  • outpatient surgery
  • postoperative admission to intensive care unit

About Britta Trautwein

Britta Trautwein is a dedicated clinical trial sponsor known for her commitment to advancing medical research and improving patient outcomes. With a strong background in clinical development and regulatory affairs, she leads initiatives that prioritize innovation and ethical standards in clinical trials. Her expertise encompasses a range of therapeutic areas, ensuring robust study designs and effective collaboration with research institutions. Through her leadership, Britta Trautwein fosters an environment of transparency and integrity, driving projects that contribute to the advancement of healthcare and the discovery of new treatment options.

Locations

Ulm, , Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials